Merrimack Pharmaceuticals (anti-HER3 programs)

Business Data, Corporate Office and Headquarter Address

About

Merrimack Pharmaceuticals (anti-HER3 programs) is Buildings and Property in United States that focus on cancer treatment business. They cover business area such as cancer treatment, Cambridge, Massachusetts.

Business Type

Buildings and Property

Country

United States

Founded

-

Company Focus

Cancer Treatment

Website

-

Corporate Office and Headquarter Office address:

One Broadway
14th floor
Cambridge, MA 02142
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

cancer treatmentCambridgeMassachusetts

* We use standard office opening hours in near Merrimack Pharmaceuticals (anti-HER3 programs)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Merrimack Pharmaceuticals (anti-HER3 programs) Frequently Asked Questions

What or who is Merrimack Pharmaceuticals (anti-HER3 programs)?

Merrimack Pharmaceuticals (anti-HER3 Programs) is Buildings and Property business from United States that founded in - ( years old in ), Merrimack Pharmaceuticals (anti-HER3 programs) business is focusing on Cancer Treatment.

Where is Merrimack Pharmaceuticals (anti-HER3 programs) headquarter and corporate office address?

Merrimack Pharmaceuticals (anti-HER3 programs) headquarter office and corporate office address is located in One Broadway 14th floor Cambridge, MA 02142 United States.

Where is Merrimack Pharmaceuticals (anti-HER3 programs) country origins?

Merrimack Pharmaceuticals (anti-HER3 programs) was founded in United States.

What is Cancer Treatment business focus on?

In , Merrimack Pharmaceuticals (anti-HER3 programs) is currently focus on cancer treatment sector.

Disclaimer: This website is not affiliated with Merrimack Pharmaceuticals (anti-HER3 programs), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.